The costs of late detection of developmental dysplasia of the hip

Timothy Woodacre1, A Dhadwal, T Ball

  • 1Royal Devon and Exeter Hospital, Barrack Road, Exeter, Devon, EX2 5DW, UK, timwoodacre@yahoo.co.uk.

Insights

Early detection of infant hip dysplasia significantly reduces treatment costs. Late diagnosis increases complexity and leads to a sevenfold rise in treatment expenses, highlighting the need for improved early intervention strategies.

Area of Science:

  • Pediatric Orthopedics
  • Health Economics
  • Medical Screening

Background:

  • Developmental dysplasia of the hip (DDH) screening is debated for economic viability.
  • Early detection and treatment are crucial for optimal outcomes in infant hip conditions.

Purpose of the Study:

  • To evaluate the economic impact of screening for developmental dysplasia of the hip in infants.
  • To determine treatment complexity and costs associated with DDH detection and management based on age at presentation and treatment modality.

Main Methods:

  • Prospective study of 36,960 live births from 1998-2008.
  • Utilized universal clinical screening and selective ultrasound screening for infants.
  • Conducted a detailed cost analysis of disease detection and hospital treatment.

Main Results:

  • 179 infants (4.8/1,000) presented with hip dysplasia.
  • Late presenters (>3 months) incurred costs of £4,352/child, requiring surgery.
  • Early presenters (<3 months) managed with Pavlik harness cost £601/child; those failing treatment incurred higher costs (£7,052/child).

Conclusions:

  • Late detection of DDH significantly increases treatment complexity and costs.
  • Early detection and successful Pavlik harness treatment are highly cost-effective.
  • Improved strategies are needed for the 10% of early presenters who fail Pavlik harness treatment, requiring more complex interventions.
Abstract